Successful management of miliary tuberculosis after renal transplantation.
Miliary tuberculosis is the most lethal form of tubercular disease. If dissemination of tubercle bacilli occurs without therapy, death is almost certain. The importance of establishing an etiologic diagnosis as promptly as possible in patients receiving immunosuppressive therapy is self-explanatory. The presence of a life-threatening infection in these patients requires aggressive antimicrobial therapy and discontinuation of the immunosuppressive drugs until the infectious process is under control; the presence of an impaired immunologic response is responsible for the life-threatening infection and the lack of an acute rejection reaction.
D000328:Adult; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D006084:Graft Rejection; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007538:Isoniazid / Q000627:therapeutic use; D016030:Kidney Transplantation; D011183:Postoperative Complications; D011241:Prednisone / Q000627:therapeutic use; D011859:Radiography; D013307:Streptomycin / Q000627:therapeutic use; D014184:Transplantation, Homologous; D014391:Tuberculosis, Miliary / Q000000981:diagnostic imaging / Q000188:drug therapy*
D007166:Immunosuppressive Agents; D004977:Ethambutol; D007538:Isoniazid; D011241:Prednisone; D013307:Streptomycin